Showing results (111-120 of 129) with videos related to
Sort By:
Pageof 13
Journal of Hematotherapy|January 27, 1999
Cord Blood Transplantation Study (COBLT): cord blood bank standard operating proceduresJ K Fraser, M S Cairo, E L Wagner, et al.The Journal of Pediatrics|June 1, 1982
A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemiaJ R Priest, N K Ramsay, P G Steinherz, et al.Leukemia|November 21, 2008
Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international studyH A Poirel, M S Cairo, N A Heerema, et al.Leukemia|June 19, 2014
Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphomaP Satwani, Z Jin, P L Martin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicitiesF Bracho, M D Krailo, V Shen, et al.Bone Marrow Transplantation|September 7, 2010
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescentsJ Styczynski, B Tallamy, I Waxman, et al.Bone Marrow Transplantation|April 27, 2004
Outcomes of unrelated cord blood transplantation in pediatric recipientsJ Styczynski, Y-K Cheung, J Garvin, et al.Cancer|July 15, 1997
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer GroupJ D Frost, J A Hank, G H Reaman, et al.Bone Marrow Transplantation|May 7, 2014
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell diseaseM Bhatia, Z Jin, C Baker, et al.Neurology|September 15, 2006
Allogeneic stem cell transplantation corrects biochemical derangements in MNGIEM Hirano, R Martí, C Casali, et al.Pageof 13